Toxicity of Ablative Radiation Therapy in the Management of Patients with Child-Pugh B/C Liver Function and Unresectable Hepatocellular Carcinoma (HCC)
Ablative radiation for patients with decompensated liver function and HCC appears well tolerated with low rates of RILD and encouraging local control. With careful selection, these patients should be considered for inclusion in future randomized trials.
Authors
- Christine E. Eyler (ORCID: https://orcid.org/0000-0001-6113-2478)
- Devon Godfrey (ORCID: https://orcid.org/0000-0001-6406-1126)
- C. Willett
- Brian G. Czito (ORCID: https://orcid.org/0000-0001-5074-767X)
- William Sperduto (ORCID: https://orcid.org/0000-0002-3885-2044)
- Taofik Oyekunle
- Joseph K. Salama
Institutions
- Duke University (US)
- WinnMed (US)
- Duke Medical Center (US)
- Durham VA Medical Center (US)
- Mayo Clinic in Florida (US)
- Duke University Hospital (US)
Publication Details
- Journal
- Cancers
- Published
- 2026-02-19
- DOI
- https://doi.org/10.3390/cancers18040681
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00